Derik De Bruin
Stock Analyst at B of A Securities
(4.67)
# 199
Out of 4,412 analysts
110
Total ratings
66.94%
Success rate
15.8%
Average return
Main Sectors:
31 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DHR Danaher | Maintains: Neutral | $258 → $270 | $246.58 | +9.50% | 2 | Apr 24, 2024 | |
| FTRE Fortrea Holdings | Maintains: Underperform | $29 → $33 | $36.35 | -9.22% | 2 | Mar 12, 2024 | |
| SDGR Schrödinger | Maintains: Neutral | $38 → $32 | $23.97 | +33.50% | 1 | Feb 29, 2024 | |
| ILMN Illumina | Downgrades: Underperform | $140 → $100 | $122.28 | -18.22% | 5 | Dec 12, 2023 | |
| A Agilent Technologies | Downgrades: Neutral | $130 → $133 | $137.74 | -3.44% | 13 | Dec 12, 2023 | |
| DGX Quest Diagnostics | Upgrades: Buy | $140 → $160 | $134.26 | +19.17% | 4 | Dec 12, 2023 | |
| TXG 10x Genomics | Upgrades: Neutral | $36 → $54 | $27.59 | +95.72% | 4 | Dec 12, 2023 | |
| TMO Thermo Fisher | Maintains: Buy | $575 | $573.60 | +0.24% | 12 | Oct 25, 2023 | |
| LH Laboratory Corporation of America Holdings | Maintains: Buy | $238 → $230 | $198.40 | +15.93% | 2 | Sep 21, 2023 | |
| CTLT Catalent | Maintains: Underperform | $39 → $46 | $55.92 | -17.74% | 7 | Aug 31, 2023 | |
| CRL Charles River Laboratories International | Maintains: Buy | $235 → $245 | $229.03 | +6.97% | 3 | Aug 10, 2023 | |
| HOLX Hologic | Maintains: Neutral | $94 → $86 | $75.98 | +13.19% | 6 | Aug 1, 2023 | |
| STVN Stevanato Group | Maintains: Buy | $32 → $35 | $27.54 | +27.09% | 2 | Jun 16, 2023 | |
| EVO Evotec SE | Downgrades: Neutral | $13 | $5.02 | +158.96% | 1 | Jun 16, 2023 | |
| WST West Pharmaceutical Services | Upgrades: Buy | $390 → $405 | $360.43 | +12.37% | 6 | Jun 16, 2023 | |
| WAT Waters | Maintains: Neutral | $350 → $315 | $311.30 | +1.19% | 6 | May 10, 2023 | |
| EXAS Exact Sciences | Maintains: Buy | $80 → $88 | $58.85 | +49.53% | 5 | May 10, 2023 | |
| MTD Mettler-Toledo International | Maintains: Neutral | $1,650 → $1,525 | $1,238.09 | +23.17% | 4 | May 8, 2023 | |
| NEO NeoGenomics | Maintains: Neutral | $18 → $17 | $14.14 | +20.23% | 3 | Apr 11, 2023 | |
| SEER Seer, Inc. | Downgrades: Underperform | $9 → $6.5 | $1.91 | +240.31% | 1 | Jan 4, 2023 | |
| ICLR ICON PLC | Upgrades: Buy | $265 → $260 | $308.31 | -15.67% | 1 | Nov 9, 2022 | |
| DNA Ginkgo Bioworks Holdings | Downgrades: Underperform | $6 → $3 | $0.86 | +248.80% | 3 | May 18, 2022 | |
| TLIS Talis Biomedical | Maintains: Underperform | $45 → $23 | $9.14 | +146.17% | 3 | Mar 16, 2022 | |
| QGEN Qiagen | Upgrades: Buy | $61 | $41.65 | +45.91% | 4 | Oct 6, 2020 | |
| IQV IQVIA Holdings | Maintains: Buy | n/a | $234.88 | - | 1 | Jul 7, 2020 | |
| MYGN Myriad Genetics | Reiterates: Underperform | n/a | $18.18 | - | 3 | Apr 2, 2020 | |
| IDXX IDEXX Laboratories | Maintains: Buy | n/a | $499.30 | - | 2 | Nov 2, 2018 | |
| ZTS Zoetis | Maintains: Buy | n/a | $158.42 | - | 1 | Jul 30, 2018 | |
| BRKR Bruker | Maintains: Neutral | n/a | $80.97 | - | 1 | May 4, 2018 | |
| DDD 3D Systems | Downgrades: Underperform | n/a | $3.43 | - | 1 | Nov 1, 2017 | |
| PAHC Phibro Animal Health | Reinstates: Underperform | n/a | $12.73 | - | 1 | Aug 23, 2017 |
Danaher
Apr 24, 2024
Maintains: Neutral
Price Target: $258 → $270
Current: $246.58
Upside: +9.50%
Fortrea Holdings
Mar 12, 2024
Maintains: Underperform
Price Target: $29 → $33
Current: $36.35
Upside: -9.22%
Schrödinger
Feb 29, 2024
Maintains: Neutral
Price Target: $38 → $32
Current: $23.97
Upside: +33.50%
Illumina
Dec 12, 2023
Downgrades: Underperform
Price Target: $140 → $100
Current: $122.28
Upside: -18.22%
Agilent Technologies
Dec 12, 2023
Downgrades: Neutral
Price Target: $130 → $133
Current: $137.74
Upside: -3.44%
Quest Diagnostics
Dec 12, 2023
Upgrades: Buy
Price Target: $140 → $160
Current: $134.26
Upside: +19.17%
10x Genomics
Dec 12, 2023
Upgrades: Neutral
Price Target: $36 → $54
Current: $27.59
Upside: +95.72%
Thermo Fisher
Oct 25, 2023
Maintains: Buy
Price Target: $575
Current: $573.60
Upside: +0.24%
Laboratory Corporation of America Holdings
Sep 21, 2023
Maintains: Buy
Price Target: $238 → $230
Current: $198.40
Upside: +15.93%
Catalent
Aug 31, 2023
Maintains: Underperform
Price Target: $39 → $46
Current: $55.92
Upside: -17.74%
Charles River Laboratories International
Aug 10, 2023
Maintains: Buy
Price Target: $235 → $245
Current: $229.03
Upside: +6.97%
Hologic
Aug 1, 2023
Maintains: Neutral
Price Target: $94 → $86
Current: $75.98
Upside: +13.19%
Stevanato Group
Jun 16, 2023
Maintains: Buy
Price Target: $32 → $35
Current: $27.54
Upside: +27.09%
Evotec SE
Jun 16, 2023
Downgrades: Neutral
Price Target: $13
Current: $5.02
Upside: +158.96%
West Pharmaceutical Services
Jun 16, 2023
Upgrades: Buy
Price Target: $390 → $405
Current: $360.43
Upside: +12.37%
Waters
May 10, 2023
Maintains: Neutral
Price Target: $350 → $315
Current: $311.30
Upside: +1.19%
Exact Sciences
May 10, 2023
Maintains: Buy
Price Target: $80 → $88
Current: $58.85
Upside: +49.53%
Mettler-Toledo International
May 8, 2023
Maintains: Neutral
Price Target: $1,650 → $1,525
Current: $1,238.09
Upside: +23.17%
NeoGenomics
Apr 11, 2023
Maintains: Neutral
Price Target: $18 → $17
Current: $14.14
Upside: +20.23%
Seer, Inc.
Jan 4, 2023
Downgrades: Underperform
Price Target: $9 → $6.5
Current: $1.91
Upside: +240.31%
ICON PLC
Nov 9, 2022
Upgrades: Buy
Price Target: $265 → $260
Current: $308.31
Upside: -15.67%
Ginkgo Bioworks Holdings
May 18, 2022
Downgrades: Underperform
Price Target: $6 → $3
Current: $0.86
Upside: +248.80%
Talis Biomedical
Mar 16, 2022
Maintains: Underperform
Price Target: $45 → $23
Current: $9.14
Upside: +146.17%
Qiagen
Oct 6, 2020
Upgrades: Buy
Price Target: $61
Current: $41.65
Upside: +45.91%
IQVIA Holdings
Jul 7, 2020
Maintains: Buy
Price Target: n/a
Current: $234.88
Upside: -
Myriad Genetics
Apr 2, 2020
Reiterates: Underperform
Price Target: n/a
Current: $18.18
Upside: -
IDEXX Laboratories
Nov 2, 2018
Maintains: Buy
Price Target: n/a
Current: $499.30
Upside: -
Zoetis
Jul 30, 2018
Maintains: Buy
Price Target: n/a
Current: $158.42
Upside: -
Bruker
May 4, 2018
Maintains: Neutral
Price Target: n/a
Current: $80.97
Upside: -
3D Systems
Nov 1, 2017
Downgrades: Underperform
Price Target: n/a
Current: $3.43
Upside: -
Phibro Animal Health
Aug 23, 2017
Reinstates: Underperform
Price Target: n/a
Current: $12.73
Upside: -